Gilead Says Shorter Remdesivir Regimen Is Effective And Drug Met Primary Endpoint In Government Study by The Options Insider | Apr 29, 2020 | News Feed https://www.marketwatch.com/story/gileads-stock-halted-says-remdesivir-met-primary-endpoint-in-government-study-2020-04-29?mod=mw_latestnews
